HHS Stock Analysis: Buy, Sell, or Hold?
$4.60
-0.04 (-0.97%)
▼
5d:
+0.22%
30d:
+7.98%
90d:
+91.67%
WAIT
LOW Confidence
Analysis Updated: Sep 25, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HHS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HHS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.20
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.61
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $4.60, which is considered extended relative to its 30-day fair value range of $4.00 to $4.57. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.3) compared to its historical average (2.8). At these levels, the market is pricing in 15.8% annual earnings growth.
Technical Outlook: Technically, HHS is in a strong uptrend. The price is approaching resistance at $4.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HHS scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.50 (+280.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HHS is in a strong uptrend. The price is approaching resistance at $4.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HHS scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.50 (+280.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.00 -
$4.57
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.9%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 280.4% below Wall St target ($17.50)
- BULLISH: Expecting earnings turnaround to 15.8% growth with -1.7% revenue growth
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.00 -
$4.57
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.24
Resistance Level
$4.67
Current Trend
Strong Uptrend
Technical data as of
Sep 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.30
Wall Street Target
$17.50
(+280.4%)
Revenue Growth (YoY)
-1.7%
Earnings Growth (YoY)
-90.3%
Profit Margin
-3.7%
Valuation Premium vs History
+15.8% premium
PE vs Historical
4.3 vs 2.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+15.8%
(market-implied from PE analysis)
1-Year Target
$5.33
(+16%)
2-Year Target
$6.17
(+34%)
3-Year Target
$7.14
(+55%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$4.65
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 26, 2026 1:06 AM ET
Data refreshes hourly during market hours. Next update: 2:06 AM
Data refreshes hourly during market hours. Next update: 2:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HON
Honeywell International … |
BUY
26 analysts |
$263 | 54 HOLD |
|
MMM
3M Company |
BUY
19 analysts |
$186 | 69 BUY |
|
BBU
Brookfield Business Part… |
STRONG BUY
6 analysts |
$41 | 52 HOLD |
|
VMI
Valmont Industries Inc |
STRONG BUY
5 analysts |
$625 | 48 HOLD |
|
PAM
Pampa Energia SA ADR |
BUY
8 analysts |
$121 | 36 SELL |